Amfetamine (International)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N06BA01
CAS registry number (Chemical Abstracts Service)
0000300-62-9
Chemical Formula
C9-H13-N
Molecular Weight
135
Therapeutic Categories
Central stimulant
Sympathomimetic agent, indirect acting
Chemical Name
(RS)-α-Metylphenetylamine (BAN)
Foreign Names
- Amfetaminum (Latin)
- Amfetamin (German)
- Amfétamine (French)
- Anfetamina (Spanish)
Generic Names
- Amfetamina (OS: DCIT)
- Amfetamine (OS: BAN)
- Amphétamine (OS: DCF)
- Amphetamine (IS)
- Benzpropamin (IS)
- CERM 1767 (IS)
- Phenylisopropylamin (IS)
- Racemic Desoxynorephedrine (IS)
- UNII-CK833KGX7E (IS)
- Amfetamine Sulfate (OS: BANM)
- Amphetamine Sulphate (IS)
- Phenaminum (USSRP) (IS)
- Phenylaminopropanum racemicum sulfuricum (IS)
- UNII-6DPV8NK46S (IS)
- Amfetamine Sulfate (PH: BP 2018)
- Amfetamine sulfate (PH: Ph. Eur. 9)
- Amfetamini sulfas (PH: Ph. Eur. 9)
- Amfetaminsulfat (PH: Ph. Eur. 9)
- Amphétamine (sulfate d') (PH: Ph. Eur. 8)
- Amphetamine Sulfate (PH: USP 41)
Brand Names
- Adzenys XR-ODT
Neos, United States - Anfetamina L.CH.
Laboratorio Chile, Chile - Dyanavel XR
Tris Pharma, United States - ACT Amphetamine XR [+ Amfetamine Sulfate, + Dexamfetamine Saccharate, + Dexamfetamine Sulfate]
Actavis Pharma, Canada - Adderall XR [+ Dexamfetamine]
Shire Pharma, Canada - Adderall XR 10 [+ Dexamfetamine]
Shire, United States - Adderall XR 15 [+ Dexamfetamine]
Shire, United States - Adderall XR 20 [+ Dexamfetamine]
Shire, United States - Adderall XR 25 [+ Dexamfetamine]
Shire, United States - Adderall XR 30 [+ Dexamfetamine]
Shire, United States - Adderall XR 5 [+ Dexamfetamine]
Shire, United States - Attent 10mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Attent 20mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Attent 30mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Attent 5mg [+ Dexamfetamine]
Barr Laboratories Inc., Israel - Dextroamp Saccharate, AMP Aspartate, Dextroamp Sulfate and AMP Sulfate [+ Amfetamine]
Sandoz, United States - Dextroamp Saccharate, AMP Aspartate, Dextroamp Sulfate and AMP Sulfate [+ Dexamfetamine]
Actavis, United States; Alvogen, United States; Aurolife, United States; Barr, United States; Epic Pharma, United States; IMPAX Laboratories, United States; Mallinckrodt, United States; Mylan, United States; Sun Pharma, United States; Teva, United States - Mydayis [+ Dextromethorphan]
Shire, United States - PMS-Amphetamines [+ Dexamfetamine]
Pharmascience, Canada - Sandoz Amphetamine [+ Dexamfetamine]
Sandoz, Canada - ACT Amphetamine XR [+ Amfetamine Aspartate, + Dexamfetamine Sulfate, + Dexamfetamine Saccharate]
Actavis Pharma, Canada - Evekeo
Arbor Pharmaceuticals, United States
Glossary
Term | Definition |
---|---|
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
IS | Inofficial Synonym |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Further information on drug naming conventions: International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.